Ryan J. Watts - President and CEO, Director at Denali Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
DNLI on Nasdaq
All Insider Reports
All Insider Reports

Ryan J. Watts - trading volume in the past year for Denali Therapeutics Inc.

Holdings reported by Ryan J. Watts for Denali Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,152,604 $33,472,992 $15.55 03 Sep 2025 Indirect
Common Stock 253,071 $3,935,254 $15.55 03 Sep 2025 Direct
Stock Option (right to buy) 20,369 09 Jul 2025 Direct Common Stock

Transactions reported by Ryan J. Watts for Denali Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.